Clew (Decision/Risk Analysis) Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
30
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$10M
- Investors
-
7
Clew (Decision/Risk Analysis) General Information
Description
Developer of a predictive analytics platform designed to guide healthcare providers in predicting the patient's clinical state. The company's platform utilizes machine learning analytics that helps to predict life-threatening deterioration in real-time and delivers predictive warnings during all phases of a patient's stay in the ICU, enabling healthcare providers to provide an informed clinical decisions to their patients.
Contact Information
Website
www.clewmed.com
Formerly Known As
Intensix
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Primary Office
- 5 Hamelecha Street
- Poleg
- Netanya 4250574
- Israel
+972 00-000-0000
Clew (Decision/Risk Analysis) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series B) | 15-Jan-2020 | $10M | 0000 | Completed | Generating Revenue | |
| 6. Early Stage VC | 27-Dec-2017 | 000.00 | 0000 | Completed | Generating Revenue | |
| 5. Early Stage VC (Series A) | 08-Feb-2017 | 00.00 | 000.00 | Completed | Generating Revenue | |
| 4. Accelerator/Incubator | 09-Jun-2016 | 000.00 | 00.00 | Completed | Generating Revenue | |
| 3. Accelerator/Incubator | 01-Jan-2016 | 00.00 | Completed | Generating Revenue | ||
| 2. Accelerator/Incubator | 20-Oct-2015 | $2.2M | Completed | Generating Revenue | ||
| 1. Seed Round | 01-Jan-2015 | $2.2M | $2.2M | Completed | Generating Revenue |
Clew (Decision/Risk Analysis) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Clew (Decision/Risk Analysis) Executive Team (14)
Clew (Decision/Risk Analysis) Board Members (9)
| Name | Representing | Role | Since |
|---|---|---|---|
| Ariel Moses | Agate Medical Investments | Board Member | 000 0000 |
| Barbara Lubash | Self | Board Member | 000 0000 |
| Daniel Talmor | Self | Board Member | 000 0000 |
| Itai Pessach | Clew (Decision/Risk Analysis) | Medical Director & Board Member | 000 0000 |
| Ittai Harel | Pitango Venture Capital | Board Member | 000 0000 |
Clew (Decision/Risk Analysis) Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Clew (Decision/Risk Analysis) Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Relyens | Impact Investing | Minority | 000 0000 | 000000 0 | |
| Agate Medical Investments | Venture Capital | Minority | 000 0000 | 000000 0 | |
| 8200 EISP | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| MedTech Innovator | Accelerator/Incubator | 000 0000 | 000000 0 | ||
| Healthbox | Accelerator/Incubator | 000 0000 | 000000 0 |